JPMorgan Chase & Co. raised its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) by 106.9% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 109,837 shares of the company’s stock after purchasing an additional 56,752 shares during the period. JPMorgan Chase & Co.’s holdings in U.S. Physical Therapy were worth $9,331,000 as of its most recent filing with the SEC.
Other institutional investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new position in shares of U.S. Physical Therapy during the 3rd quarter valued at approximately $845,000. Geode Capital Management LLC boosted its position in shares of U.S. Physical Therapy by 1.2% in the second quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after purchasing an additional 4,306 shares during the period. Bank of New York Mellon Corp boosted its position in shares of U.S. Physical Therapy by 4.9% in the second quarter. Bank of New York Mellon Corp now owns 131,556 shares of the company’s stock worth $10,288,000 after purchasing an additional 6,190 shares during the period. CenterBook Partners LP increased its stake in shares of U.S. Physical Therapy by 189.0% in the second quarter. CenterBook Partners LP now owns 47,014 shares of the company’s stock worth $3,676,000 after purchasing an additional 30,746 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in shares of U.S. Physical Therapy by 477.7% during the 3rd quarter. SG Americas Securities LLC now owns 13,593 shares of the company’s stock valued at $1,155,000 after purchasing an additional 11,240 shares during the period.
Analyst Ratings Changes
Several research analysts recently weighed in on USPH shares. Barrington Research reaffirmed an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a report on Friday, February 20th. JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a research note on Monday, November 24th. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Finally, Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $105.33.
U.S. Physical Therapy Stock Performance
USPH opened at $81.30 on Friday. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 57.25, a PEG ratio of 2.07 and a beta of 1.30. The company has a fifty day moving average of $83.84 and a 200 day moving average of $82.40. U.S. Physical Therapy, Inc. has a fifty-two week low of $62.77 and a fifty-two week high of $93.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.20 and a current ratio of 1.01.
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.67 EPS for the quarter, hitting the consensus estimate of $0.67. The business had revenue of $202.73 million for the quarter, compared to analysts’ expectations of $200.10 million. U.S. Physical Therapy had a net margin of 5.07% and a return on equity of 8.75%. The business’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.51 EPS. As a group, sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.
U.S. Physical Therapy Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, April 10th. Shareholders of record on Friday, March 13th will be issued a dividend of $0.46 per share. The ex-dividend date is Friday, March 13th. This represents a $1.84 annualized dividend and a yield of 2.3%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.45. U.S. Physical Therapy’s dividend payout ratio (DPR) is 126.76%.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
